Dr. Ganly on a Postoperative Nomogram for Predicting Cancer-Specific Mortality in MTC

Video

Ian Ganly, MD, PhD, from Memorial Sloan Kettering Cancer Center, discusses the development of a postoperative nomogram for predicting cancer-specific mortality in MTC.

Ian Ganly, MD, PhD, head and neck surgeon, Memorial Sloan Kettering Cancer Center, discusses the development of a postoperative nomogram for predicting cancer-specific mortality in patients with medullary thyroid cancer (MTC).

Survival outcomes are influenced by numerous factors, including stage at presentation and the ability to resect all of the disease. Ganly says the aim of the project was to design a model that incorporates clinical, pathological, and biochemical variables to determine cancer-specific mortality.

The statistical model was designed by using regression analysis. The result was a nomogram, which could be used to predict outcomes, Ganly says. The nomogram consisted of 7 factors that are the most predictive of outcomes. These factors included TNM status, age, gender, vascular invasion, and postoperative calcitonin levels.

The nomogram had a concordance index of 0.77, Ganly says. However, the nomogram was only developed using data from 250 patients and needs to be validated in other populations at other institutions.

<<<

View more from the 2014 ATA Annual Meeting

Related Videos
Alessandro Villa, DDS, PhD, MPH
Patrick I. Borgen, MD
Anna Lee, MD, MPH
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology